Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors.
Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors.
复制标题
胞质磷酸烯醇丙酮酸羧激酶的上调是肿瘤再生的黑色素瘤细胞中的一个关键代谢事件
DOI:
10.1158/0008-5472.can-14-2615
复制
发表时间:
2015-04-01
期刊:
影响因子:
11.2
通讯作者:
Huang B
中科院分区:
文献类型:
--
作者:
Li Y;Luo S;Ma R;Liu J;Xu P;Zhang H;Tang K;Ma J;Zhang Y;Liang X;Sun Y;Ji T;Wang N;Huang B
While metabolic defects have been investigated extensively in differentiated tumor cells, much less attention has been directed to the metabolic properties of stem-like cells that repopulate tumors (tumor-repopulating cells [TRC]). Here we show that melanoma TRCs cultured in 3D soft fibrin gels reprogram glucose metabolism by hijacking the cytosolic enzyme phosphoenolpyruvate carboxykinase (PCK1), a key player in gluconeogenesis. Surprisingly, upregulated PCK1 in TRCs did not mediate gluconeogenesis but promoted glucose side-branch metabolism, including in the serine and glycerol-3-phosphate pathways. Moreover, this retrograde glucose carbon flow strengthened rather than antagonized glycolysis and glucose consumption. Silencing PCK1 or inhibiting its enzymatic activity slowed the growth of TRCs in vitro and impeded tumorigenesis in vivo. Overall, our work unveiled metabolic features of tumor-repopulating cells in melanoma that have implications for targeting a unique aspect of this disease.